Literature DB >> 12748228

Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunction.

S Sakurai, H Adachi, A Hasegawa, H Hoshizaki, S Oshima, K Taniguchi, M Kurabayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12748228      PMCID： PMC1767693          DOI： 10.1136/heart.89.6.661

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure.

Authors:  T P Chua; P Ponikowski; D Harrington; S D Anker; K Webb-Peploe; A L Clark; P A Poole-Wilson; A J Coats
Journal:  J Am Coll Cardiol       Date:  1997-06       Impact factor: 24.094

2.  Impairment of ventilatory efficiency in heart failure: prognostic impact.

Authors:  F X Kleber; G Vietzke; K D Wernecke; U Bauer; C Opitz; R Wensel; A Sperfeld; S Gläser
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

3.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

Authors:  T Tsutamoto; A Wada; K Maeda; T Hisanaga; Y Maeda; D Fukai; M Ohnishi; Y Sugimoto; M Kinoshita
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

4.  Exercise testing in the evaluation of the patient with chronic cardiac failure.

Authors:  K T Weber; J R Wilson; J S Janicki; M J Likoff
Journal:  Am Rev Respir Dis       Date:  1984-02

5.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690
  5 in total
  6 in total

Review 1.  The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.

Authors:  Craig R Butler; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction.

Authors:  Nuttarak Sasipong; Philipp Schlegel; Julia Wingert; Christoph Lederer; Eric Meinhardt; Amelie Ziefer; Constanze Schmidt; Kleopatra Rapti; Cornelia Thöni; Norbert Frey; Patrick Most; Hugo A Katus; Philip W J Raake
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 12.910

Review 3.  Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease.

Authors:  Karolina Idzikowska; Marzenna Zielińska
Journal:  J Int Med Res       Date:  2018-07-20       Impact factor: 1.671

4.  Classification of severe aortic stenosis and outcomes after aortic valve replacement.

Authors:  Yura Ahn; Se Jin Choi; Soyeoun Lim; Joon Bum Kim; Jong-Min Song; Duk-Hyun Kang; Jae-Kwan Song; Hwa Jung Kim; Joon-Won Kang; Dong Hyun Yang; Dae-Hee Kim; Hyun Jung Koo
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

5.  Reverse re-modelling chronic heart failure by reinstating heart rate variability.

Authors:  J Shanks; Y Abukar; N A Lever; M Pachen; I J LeGrice; D J Crossman; A Nogaret; J F R Paton; R Ramchandra
Journal:  Basic Res Cardiol       Date:  2022-02-01       Impact factor: 12.416

6.  Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.

Authors:  Julie Kelly; Judy Cheng; Rhynn Malloy; Kenneth Lupi
Journal:  J Cardiovasc Pharmacol       Date:  2020-05       Impact factor: 3.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.